🇺🇸 FDA
Patent

US 9446125

Anti-EphA2 antibodies and methods of use thereof

granted A61KA61K39/39558A61K47/60

Quick answer

US patent 9446125 (Anti-EphA2 antibodies and methods of use thereof) held by THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, BERKE expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, BERKE
Grant date
Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K39/39558, A61K47/60, A61P, A61P35/00